Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	The Word Brain 2015 – Free PDF | Print | Web A short guide to fast language learning	Free Abstracts

Malignant Melanoma

Free Subscription Articles published in Arch Dermatol Retrieve available abstracts of 73 articles: HTML format Text format

Single Articles

December 2012
1. MA L , Dominguez AR, Collins GR, Kia KF, et al
   Hidradenitis Suppurativa, Eruptive Melanocytic Nevi, and Keratosis Pilaris-like Eruption in a Patient Treated With Vemurafenib.
   Arch Dermatol. 2012;148:1428-9.
   PubMed     Text format    
   
   
   October 2012
2. SLADDEN MJ
   Sufficiency and Safety of 2-cm Excision Margin for Stage IIA Through Stage IIC Cutaneous Melanoma.
   Arch Dermatol. 2012;148:1197-8.
   PubMed     Text format    
   
   
   
3. HANDLER MZ , Ross AL, Shiman MI, Elgart GW, et al
   Potential role of human growth hormone in melanoma growth promotion.
   Arch Dermatol. 2012;148:1179-82.
   PubMed     Text format     Abstract available
   
   
   
4. SANCHEZ MI , Rabinovitz HS, Oliverio MC, Elgart GW, et al
   Confocal microscopy of challenging dermoscopic diagnoses.
   Arch Dermatol. 2012;148:1224.
   PubMed     Text format    
   
   
   September 2012
5. GRANGE F , Barbe C, Aubin F, Lipsker D, et al
   Clinical and Sociodemographic Characteristics Associated With Thick Melanomas: A Population-Based, Case-Case Study in France.
   Arch Dermatol. 2012 Sep 17:1-7. doi: 10.1001/archdermatol.2012.2937.
   PubMed     Text format     Abstract available
   
   
   
6. ANEJA S , Aneja S, Bordeaux JS
   On dermatologist density and melanoma mortality-reply.
   Arch Dermatol. 2012;148:1092-3.
   PubMed     Text format    
   
   
   
7. LOTT JP
   On dermatologist density and melanoma mortality.
   Arch Dermatol. 2012;148:1092-3.
   PubMed     Text format    
   
   
   
8. WELLS R , Gutkowicz-Krusin D, Veledar E, Toledano A, et al
   Comparison of Diagnostic and Management Sensitivity to Melanoma Between Dermatologists and MelaFind: A Pilot Study.
   Arch Dermatol. 2012;148:1083-4.
   PubMed     Text format    
   
   
   
9. MARTIRES KJ , Barnholtz-Sloan JS, Bordeaux JS
   A call for consistent reporting of regression in melanoma.
   Arch Dermatol. 2012;148:1081-3.
   PubMed     Text format    
   
   
   
10. FERRANDIZ L , Ruiz-de-Casas A, Martin-Gutierrez FJ, Peral-Rubio F, et al
    Effect of teledermatology on the prognosis of patients with cutaneous melanoma.
    Arch Dermatol. 2012;148:1025-8.
    PubMed     Text format     Abstract available
    
    
    
11. PAWLAK MT , Bui M, Amir M, Burkhardt DL, et al
    Legislation restricting access to indoor tanning throughout the world.
    Arch Dermatol. 2012;148:1006-12.
    PubMed     Text format     Abstract available
    
    
    
12. CHEN LL , Wang SQ
    Post-California tanning ban: a brief update on current youth access laws.
    Arch Dermatol. 2012;148:1071-2.
    PubMed     Text format    
    
    
    August 2012
13. HAENSSLE HA , Kraus SL, Brehmer F, Kretschmer L, et al
    Dynamic Changes in Nevi of a Patient With Melanoma Treated With Vemurafenib: Importance of Sequential Dermoscopy.
    Arch Dermatol. 2012 Aug 20:1-3. doi: 10.1001/archdermatol.2012.2649.
    PubMed     Text format     Abstract available
    
    
    
14. GUPTA M , Huang V, Linette G, Cornelius L, et al
    Unusual complication of vemurafenib treatment of metastatic melanoma: exacerbation of acantholytic dyskeratosis complicated by kaposi varicelliform eruption.
    Arch Dermatol. 2012;148:966-8.
    PubMed     Text format    
    
    
    
15. VASSALLO C , Derlino F, Torti S, Carugno A, et al
    Longitudinal deep fissure and distal onycholysis of the right thumb. Amelanotic subungual melanoma.
    Arch Dermatol. 2012;148:947-52.
    PubMed     Text format    
    
    
    
16. WALDMANN A , Nolte S, Geller AC, Katalinic A, et al
    Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360 288 whole-body examinations.
    Arch Dermatol. 2012;148:903-10.
    PubMed     Text format     Abstract available
    
    
    July 2012
17. KASPARIAN NA , Branstrom R, Chang YM, Affleck P, et al
    Skin Examination Behavior: The Role of Melanoma History, Skin Type, Psychosocial Factors, and Region of Residence in Determining Clinical and Self-conducted Skin Examination.
    Arch Dermatol. 2012 Jul 16:1-10. doi: 10.1001/archdermatol.2012.1817.
    PubMed     Text format     Abstract available
    
    
    
18. KUNDU RV
    Barriers in melanoma detection in ethnic minorities: comment on anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998-2007.
    Arch Dermatol. 2012;148:801-2.
    PubMed     Text format    
    
    
    
19. MYLES ZM , Buchanan N, King JB, Singh S, et al
    Anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998-2007.
    Arch Dermatol. 2012;148:797-801.
    PubMed     Text format     Abstract available
    
    
    
20. COUPS EJ , Stapleton JL, Hudson SV, Medina-Forrester A, et al
    Skin cancer screening among Hispanic adults in the United States: results from the 2010 national health interview survey.
    Arch Dermatol. 2012;148:861-3.
    PubMed     Text format    
    
    
    
21. MCCLENAHAN P , Blake T, Douglas N, Gilmore S, et al
    Quantifying the orientation of acquired melanocytic nevi on the back.
    Arch Dermatol. 2012;148:857-9.
    PubMed     Text format    
    
    
    
22. RUSSO VA , Van Acker MM, Vander Wal JS, Sinha AA, et al
    Patterns of use of sunless tanning product alternatives to indoor tanning among female college students.
    Arch Dermatol. 2012;148:855-7.
    PubMed     Text format    
    
    
    June 2012
23. SENET P , Combemale P, Debure C, Baudot N, et al
    Malignancy and chronic leg ulcers: the value of systematic wound biopsies: a prospective, multicenter, cross-sectional study.
    Arch Dermatol. 2012;148:704-8.
    PubMed     Text format     Abstract available
    
    
    May 2012
24. ABDELMALEK M , Loosemore MP, Hurt MA, Hruza G, et al
    Geometric Staged Excision for the Treatment of Lentigo Maligna and Lentigo Maligna Melanoma: A Long-term Experience With Literature Review.
    Arch Dermatol. 2012;148:599-604.
    PubMed     Text format     Abstract available
    
    
    
25. HYDE MA , Hadley ML, Tristani-Firouzi P, Goldgar D, et al
    A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions.
    Arch Dermatol. 2012;148:592-6.
    PubMed     Text format     Abstract available
    
    
    April 2012
26. LAPRESTO L , Cranmer L, Erickson CP, Morrison L, et al
    Erythematous annular plaques on the trunk.
    Arch Dermatol. 2012;148:531-6.
    PubMed     Text format    
    
    
    March 2012
27. HUANG V , Hepper D, Anadkat M, Cornelius L, et al
    Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF Pathway.
    Arch Dermatol. 2012.
    PubMed     Text format     Abstract available
    
    
    
28. ALLOO A , Garibyan L, Leboeuf N, Lin G, et al
    Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma.
    Arch Dermatol. 2012;148:363-6.
    PubMed     Text format     Abstract available
    
    
    
29. FERNANDEZ CA , McClure LA, Leblanc WG, Clarke TC, et al
    A comparison of Florida skin cancer screening rates with those in the rest of the United States.
    Arch Dermatol. 2012;148:393-5.
    PubMed     Text format    
    
    
    
30. MAGRO CM , Crowson AN, Desman G, Zippin JH, et al
    Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions.
    Arch Dermatol. 2012;148:335-44.
    PubMed     Text format     Abstract available
    
    
    February 2012
31. RIGEL DS , Roy M, Yoo J, Cockerell CJ, et al
    Impact of Guidance From a Computer-Aided Multispectral Digital Skin Lesion Analysis Device on Decision to Biopsy Lesions Clinically Suggestive of Melanoma.
    Arch Dermatol. 2012.
    PubMed     Text format    
    
    
    
32. ANEJA S , Aneja S, Bordeaux JS
    Association of increased dermatologist density with lower melanoma mortality.
    Arch Dermatol. 2012;148:174-8.
    PubMed     Text format     Abstract available
    
    
    
33. KERL K , Kempf W, Kamarashev J, Spallone G, et al
    Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesions.
    Arch Dermatol. 2012;148:235-8.
    PubMed     Text format     Abstract available
    
    
    January 2012
34. COKKINIDES VE , Geller AC, Jemal A
    Trends in Melanoma Mortality Among Non-Hispanic Whites by Educational Attainment, 1993-2007.
    Arch Dermatol. 2012.
    PubMed     Text format     Abstract available
    
    
    
35. ZIMMER L , Livingstone E, Hillen U, Domkes S, et al
    Panniculitis With Arthralgia in Patients With Melanoma Treated With Selective BRAF Inhibitors and Its Management.
    Arch Dermatol. 2012.
    PubMed     Text format     Abstract available
    
    
    
36. OLIVERIA SA , Heneghan MK, Halpern AC, Hay JL, et al
    Communication About Family Members' Risk of Melanoma: Self-reported Practices of Dermatologists in the United States.
    Arch Dermatol. 2012.
    PubMed     Text format     Abstract available
    
    
    
37. TEJERA-VAQUERIZO A , Nagore E, Herrera-Acosta E, Martorell-Calatayud A, et al
    Prediction of Sentinel Lymph Node Positivity by Growth Rate of Cutaneous Melanoma.
    Arch Dermatol. 2012.
    PubMed     Text format     Abstract available
    
    
    
38. LIEBMAN TN , Rabinovitz HS, Balagula Y, Jaimes-Lopez N, et al
    White Shiny Structures in Melanoma and BCC.
    Arch Dermatol. 2012;148:146.
    PubMed     Text format    
    
    
    
39. KOLLITZ KM , Tcheung WJ, Scheri RP, Selim MA, et al
    An acrochordon-like melanoma metastasis.
    Arch Dermatol. 2012;148:136-7.
    PubMed     Text format    
    
    
    
40. BAHMER FA
    Charles bukowski and sylvia plath on moles and melanoma.
    Arch Dermatol. 2012;148:108.
    PubMed     Text format    
    
    
    December 2011
41. YANG GB , Barnholtz-Sloan JS, Chen Y, Bordeaux JS, et al
    Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Arch Dermatol. 2011;147:1395-402.
    PubMed     Text format     Abstract available
    
    
    
42. LIEBMAN TN , Scope A, Rabinovitz H, Braun RP, et al
    Rosettes may be observed in a range of conditions.
    Arch Dermatol. 2011;147:1468.
    PubMed     Text format    
    
    
    November 2011
43. HARRIS K , Florell SR, Papenfuss J, Kohlmann W, et al
    Melanoma Mimic: A Case of Multiple Pagetoid Spitz Nevi.
    Arch Dermatol. 2011.
    PubMed     Text format     Abstract available
    
    
    October 2011
44. KVASKOFF M , Siskind V, Green AC
    Risk Factors for Lentigo Maligna Melanoma Compared With Superficial Spreading Melanoma: A Case-Control Study in Australia.
    Arch Dermatol. 2011.
    PubMed     Text format     Abstract available
    
    
    
45. MELSKI JW
    Visualizing Bayesian analysis using a spreadsheet geometry.
    Arch Dermatol. 2011;147:1225-6.
    PubMed     Text format    
    
    
    
46. BOWEN GM , Bowen AR, Florell SR
    Lentigo maligna: one size does not fit all.
    Arch Dermatol. 2011;147:1211-3.
    PubMed     Text format    
    
    
    
47. LY L , Kelly JW, O'Keefe R, Sutton T, et al
    Efficacy of imiquimod cream, 5%, for lentigo maligna after complete excision: a study of 43 patients.
    Arch Dermatol. 2011;147:1191-5.
    PubMed     Text format     Abstract available
    
    
    
48. JAIMES N , Halpern AC
    Practice Gaps. Examination of genital area: comment on "Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction".
    Arch Dermatol. 2011;147:1187-8.
    PubMed     Text format    
    
    
    
49. MOSTOW EN
    Skin cancer detection in hair salons: opportunity knocking: comment on "skin cancer knowledge, attitudes, and behaviors in the salon".
    Arch Dermatol. 2011;147:1166.
    PubMed     Text format    
    
    
    
50. BAILEY EE , Marghoob AA, Orengo IF, Testa MA, et al
    Skin cancer knowledge, attitudes, and behaviors in the salon: a survey of working hair professionals in houston, Texas.
    Arch Dermatol. 2011;147:1159-65.
    PubMed     Text format     Abstract available
    
    
    
51. BLUM A , Simionescu O, Argenziano G, Braun R, et al
    Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction: results of a multicenter study by the International Dermoscopy Society (IDS).
    Arch Dermatol. 2011;147:1181-7.
    PubMed     Text format     Abstract available
    
    
    September 2011
52. SHAIKH WR , Xiong M, Weinstock MA
    The Contribution of Nodular Subtype to Melanoma Mortality in the United States, 1978 to 2007.
    Arch Dermatol. 2011.
    PubMed     Text format     Abstract available
    
    
    August 2011
53. CONZETT KB , Kolm I, Jelcic I, Kamarachev J, et al
    Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.
    Arch Dermatol. 2011;147:991-2.
    PubMed     Text format    
    
    
    
54. EIDE MJ , Jacobsen G, Krajenta R, Johnson D, et al
    Use of Electronic Medical Records to Ascertain Depth of SEER-Reported Melanomas of Unknown Tumor Thickness.
    Arch Dermatol. 2011;147:984-6.
    PubMed     Text format    
    
    
    July 2011
55. KOVALYSHYN I , Dusza SW, Siamas K, Halpern AC, et al
    The Impact of Physician Screening on Melanoma Detection.
    Arch Dermatol. 2011.
    PubMed     Text format     Abstract available
    
    
    
56. BIGBY M , Kim CC
    A prospective randomized controlled trial indicates that sunscreen use reduced the risk of developing melanoma.
    Arch Dermatol. 2011;147:853-4.
    PubMed     Text format    
    
    
    
57. BREWER JD , Christenson LJ, Weaver AL, Dapprich DC, et al
    Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis.
    Arch Dermatol. 2011;147:790-6.
    PubMed     Text format     Abstract available
    
    
    June 2011
58. SEPEHR A , Chao E, Trefrey B, Blackford A, et al
    Long-term Outcome of Spitz-Type Melanocytic Tumors.
    Arch Dermatol. 2011.
    PubMed     Text format     Abstract available
    
    
    
59. HU S , Kirsner RS
    Practice gaps--suboptimal skin cancer screening and delayed melanoma diagnosis in hispanics: comment on "cutaneous melanoma and other skin cancer screening among hispanics in the United States".
    Arch Dermatol. 2011;147:745-6.
    PubMed     Text format    
    
    
    
60. ANDREEVA VA , Cockburn MG
    Cutaneous melanoma and other skin cancer screening among hispanics in the United States: a review of the evidence, disparities, and need for expanding the intervention and research agendas.
    Arch Dermatol. 2011;147:743-5.
    PubMed     Text format    
    
    
    
61. MCGUIRE ST , Secrest AM, Andrulonis R, Ferris LK, et al
    Surveillance of Patients for Early Detection of Melanoma: Patterns in Dermatologist vs Patient Discovery.
    Arch Dermatol. 2011;147:673-8.
    PubMed     Text format     Abstract available
    
    
    
62. KOGA H , Saida T
    Revised 3-step dermoscopic algorithm for the management of acral melanocytic lesions.
    Arch Dermatol. 2011;147:741-3.
    PubMed     Text format    
    
    
    
63. MENZIES SW , Stevenson ML, Altamura D, Byth K, et al
    Variables Predicting Change in Benign Melanocytic Nevi Undergoing Short-term Dermoscopic Imaging.
    Arch Dermatol. 2011;147:655-9.
    PubMed     Text format     Abstract available
    
    
    May 2011
64. SOON CW , Algazi AP, Cha EN, Webb EM, et al
    NRAS-Mutant Melanoma: Response to Chemotherapy.
    Arch Dermatol. 2011;147:626-7.
    PubMed     Text format    
    
    
    
65. PHAN A , Dalle S, Marcilly MC, Bergues JP, et al
    Benign dermoscopic parallel ridge pattern variants.
    Arch Dermatol. 2011;147:634.
    PubMed     Text format    
    
    
    
66. VIOLA KV , Tolpinrud WL, Gross CP, Kirsner RS, et al
    Outcomes of referral to dermatology for suspicious lesions: implications for teledermatology.
    Arch Dermatol. 2011;147:556-60.
    PubMed     Text format     Abstract available
    
    
    April 2011
67. WONG SL , Sabel MS, Johnson TM
    Sentinel lymph node biopsy for melanoma: one procedure but many questions: comment on "prognostic usefulness of sentinel lymph node biopsy for patients who have clinically node negative, localized, primary invasive cutaneous melanoma".
    Arch Dermatol. 2011;147:415-6.
    PubMed     Text format    
    
    
    
68. BRAUN RP , Scope A, Marghoob AA
    The "blink sign" in dermoscopy.
    Arch Dermatol. 2011;147:520.
    PubMed     Text format    
    
    
    
69. SIMI L , Pinzani P, Salvianti F, Lorenzoni A, et al
    Two novel H-RAS mutations identified in a child with an atypical spitzoid tumor.
    Arch Dermatol. 2011;147:514-5.
    PubMed     Text format    
    
    
    March 2011
70. HAUSAUER AK , Swetter SM, Cockburn MG, Clarke CA, et al
    Increases in Melanoma Among Adolescent Girls and Young Women in California: Trends by Socioeconomic Status and UV Radiation Exposure.
    Arch Dermatol. 2011.
    PubMed     Text format     Abstract available
    
    
    
71. JANDA M , Neale RE, Youl P, Whiteman DC, et al
    Impact of a Video-Based Intervention to Improve the Prevalence of Skin Self-examination in Men 50 Years or Older: The Randomized Skin Awareness Trial.
    Arch Dermatol. 2011.
    PubMed     Text format     Abstract available
    
    
    February 2011
72. DUMMER R , Kerl K, Mihic D, Kamarachev J, et al
    Differential diagnosis of melanocytic lesions and molecular biology.
    Arch Dermatol. 2011;147:232-3.
    PubMed     Text format    
    
    
    
73. MONHEIT G , Cognetta AB, Ferris L, Rabinovitz H, et al
    The performance of MelaFind: a prospective multicenter study.
    Arch Dermatol. 2011;147:188-94.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Pfizer Oncology. Design: